JP2025081549A5 - - Google Patents
Info
- Publication number
- JP2025081549A5 JP2025081549A5 JP2025025886A JP2025025886A JP2025081549A5 JP 2025081549 A5 JP2025081549 A5 JP 2025081549A5 JP 2025025886 A JP2025025886 A JP 2025025886A JP 2025025886 A JP2025025886 A JP 2025025886A JP 2025081549 A5 JP2025081549 A5 JP 2025081549A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- light chain
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962874287P | 2019-07-15 | 2019-07-15 | |
| US62/874,287 | 2019-07-15 | ||
| JP2022502245A JP7695228B2 (ja) | 2019-07-15 | 2020-07-15 | ヒト及びイヌｃｔｌａ－４に対するイヌ化抗体 |
| PCT/EP2020/069924 WO2021009188A1 (en) | 2019-07-15 | 2020-07-15 | Caninized antibodies to human and canine ctla-4 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502245A Division JP7695228B2 (ja) | 2019-07-15 | 2020-07-15 | ヒト及びイヌｃｔｌａ－４に対するイヌ化抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025081549A JP2025081549A (ja) | 2025-05-27 |
| JP2025081549A5 true JP2025081549A5 (enExample) | 2025-10-10 |
Family
ID=71620455
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502245A Active JP7695228B2 (ja) | 2019-07-15 | 2020-07-15 | ヒト及びイヌｃｔｌａ－４に対するイヌ化抗体 |
| JP2025025886A Pending JP2025081549A (ja) | 2019-07-15 | 2025-02-20 | ヒト及びイヌｃｔｌａ－４に対するイヌ化抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502245A Active JP7695228B2 (ja) | 2019-07-15 | 2020-07-15 | ヒト及びイヌｃｔｌａ－４に対するイヌ化抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220251209A1 (enExample) |
| EP (1) | EP3999539A1 (enExample) |
| JP (2) | JP7695228B2 (enExample) |
| CN (2) | CN119307505A (enExample) |
| AU (1) | AU2020312687A1 (enExample) |
| BR (1) | BR112022000604A2 (enExample) |
| CA (1) | CA3145347A1 (enExample) |
| WO (1) | WO2021009188A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022000604A2 (pt) * | 2019-07-15 | 2022-03-03 | Intervet Int Bv | Anticorpos caninizados para ctla-4 humana |
| US20240209096A1 (en) | 2022-12-27 | 2024-06-27 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| AU2024210302A1 (en) | 2023-01-20 | 2025-09-04 | Invetx, Inc. | Bispecific binding agents for use in companion animals |
| CN117343185B (zh) * | 2023-12-06 | 2024-03-01 | 北京伟杰信生物科技有限公司 | 一种抗犬pd-1抗体及其用途 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| DE3668186D1 (de) | 1985-04-01 | 1990-02-15 | Celltech Ltd | Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert. |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| SG143018A1 (en) | 1998-12-23 | 2008-06-27 | Pfizer | Human monoclonal antibodies to ctla-4 |
| WO2000061739A1 (fr) | 1999-04-09 | 2000-10-19 | Kyowa Hakko Kogyo Co., Ltd. | Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle |
| US7605238B2 (en) | 1999-08-24 | 2009-10-20 | Medarex, Inc. | Human CTLA-4 antibodies and their uses |
| EP1268794A2 (en) * | 2000-04-07 | 2003-01-02 | Heska Corporation | Compositions and methods related to canine igg and canine il-13 receptors |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| CA2469833C (en) * | 2001-12-21 | 2008-05-20 | Idexx Laboratories, Inc. | Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| GB0903325D0 (en) | 2009-02-26 | 2009-04-08 | Univ Aberdeen | Antibody molecules |
| JP2012521784A (ja) * | 2009-03-30 | 2012-09-20 | ベーリンガー・インゲルハイム・インテルナツィオナール・ゲーエムバーハー | イヌＦｃ部分を含む融合タンパク質 |
| GB201103955D0 (en) | 2011-03-09 | 2011-04-20 | Antitope Ltd | Antibodies |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| CA2851758A1 (en) * | 2011-10-13 | 2013-04-18 | Nvip Pty Ltd | Canine/feline cd20 binding epitope and compositions for binding thereto |
| ES2894852T3 (es) * | 2012-06-06 | 2022-02-16 | Zoetis Services Llc | Anticuerpos anti-NGF caninizados y métodos de los mismos |
| EP4566623A3 (en) * | 2013-12-20 | 2025-08-20 | Intervet International B.V. | Caninized antibodies |
| EP3201230B1 (en) | 2014-09-30 | 2020-12-23 | Intervet International B.V. | Pd-l1 antibodies binding canine pd-l1 |
| CN107683291B (zh) * | 2015-04-02 | 2021-11-19 | 英特维特国际股份有限公司 | 针对犬白介素-4受体α的抗体 |
| WO2017062615A2 (en) | 2015-10-08 | 2017-04-13 | Macrogenics, Inc. | Combination therapy for the treatment of cancer |
| EP4541807A3 (en) | 2015-12-18 | 2025-09-24 | Intervet International B.V. | Caninized human antibodies to human and canine il-4r alpha |
| CN109641949B (zh) * | 2016-08-26 | 2023-09-15 | 赛诺菲 | 促进选择性轻链配对的多特异性抗体 |
| WO2020056393A1 (en) * | 2018-09-14 | 2020-03-19 | Kindred Biosciences, Inc. | Anti-il4 receptor antibodies for veterinary use |
| BR112022000604A2 (pt) * | 2019-07-15 | 2022-03-03 | Intervet Int Bv | Anticorpos caninizados para ctla-4 humana |
-
2020
- 2020-07-15 BR BR112022000604A patent/BR112022000604A2/pt unknown
- 2020-07-15 CA CA3145347A patent/CA3145347A1/en active Pending
- 2020-07-15 CN CN202411315030.1A patent/CN119307505A/zh active Pending
- 2020-07-15 EP EP20740613.3A patent/EP3999539A1/en active Pending
- 2020-07-15 US US17/626,242 patent/US20220251209A1/en active Pending
- 2020-07-15 AU AU2020312687A patent/AU2020312687A1/en active Pending
- 2020-07-15 CN CN202080050832.8A patent/CN114174336B/zh active Active
- 2020-07-15 JP JP2022502245A patent/JP7695228B2/ja active Active
- 2020-07-15 WO PCT/EP2020/069924 patent/WO2021009188A1/en not_active Ceased
-
2025
- 2025-02-20 JP JP2025025886A patent/JP2025081549A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025081549A5 (enExample) | ||
| AU2018203170B2 (en) | Multimeric Fusion Protein Vaccine And Immunotherapeutic | |
| US7786269B2 (en) | Antibody to latent membrane proteins and uses thereof | |
| JP2025109759A5 (enExample) | ||
| JP2638652B2 (ja) | カケクチンと反応するモノクロナール抗体 | |
| EP3048115B1 (en) | Monoclonal antibodies for ebola and marburg viruses | |
| CN102690789B (zh) | 分泌破伤风外毒素单克隆抗体的杂交瘤细胞株及由其制备的单克隆抗体、Fab抗体与应用 | |
| WO2023009028A1 (ru) | Однодоменное антитело и его модификации, специфически связывающиеся с rbd s белка вируса sars-cov-2 | |
| WO2014043215A1 (en) | Bi-specifc diabodies for masking and targeting vaccines | |
| CA2539172C (fr) | Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine | |
| CN115461078A (zh) | 通过与改变的Fc片段形成融合蛋白增强蛋白/肽抗原免疫原性的方法 | |
| CN102558306B (zh) | 旋毛虫副肌球蛋白b细胞抗原表位、其组合物及用途 | |
| JPWO2020011972A5 (enExample) | ||
| JPWO2020071554A5 (enExample) | ||
| WO1999022008A1 (en) | Inducer for production of antigen-specific antibody, expression vector containing gene therefor, and method of inducing production of antigen-specific antibody | |
| CN117903301A (zh) | 特异性结合轮状病毒的抗体或其抗原结合片段 | |
| CN118085082A (zh) | 抗猫TNF-α单克隆抗体及其应用 | |
| CN116444665A (zh) | 针对新冠病毒SARS-CoV-2糖蛋白RBD区域的单克隆抗体及其应用 | |
| CN114957479A (zh) | 抗H1N1流感病毒双特异性中和抗体Bis-Hu11-1及其应用 | |
| WO2008107641A1 (en) | Liposome preparation | |
| JP6756950B2 (ja) | ヒトヘルペスウイルス６ｂ抗原組成物 | |
| Wang et al. | An engineered canine-mouse chimeric neutralizing antibody provides therapeutic effects against Canine parvovirus infection | |
| EP4628095A1 (en) | Fusion protein and granulated antigen comprising same | |
| Coelho | Isolation of human recombinant antibodies anti-SARS-CoV-2 by synthetic methods | |
| JPWO2021070181A5 (enExample) |